Open access
Aug 2026
Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates
While vaccines conferring leaky protection against infection and disease tested in settings with very high ARI could modestly underestimate efficacy, trials could be adequately powered with a fraction of the sample size in such settings.
J. Andrews, S. Hermans, Richard G. White et al.
· Vaccine · 0 citations